Subscribe To
Gsk chronic kidney disease drug receives green light
The US Food and Drug Administration (FDA) has given the green light to Jesduvroq, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-P...
February 2, 2023, 5:58 am
Polarean imaging hails as a 'major milestone' fda designation for xenoview
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) hailed as a ‘major milestone' the granting of new chemical entity (NCE) status by the US Food & Drug Admi...
February 2, 2023, 2:48 am
Moderna (mrna) rsv jab for older adults gets fda breakthrough tag
Moderna (MRNA) announces that the FDA granted Breakthrough Therapy Designation to its respiratory syncytial virus (RSV) vaccine candidate, mRNA-1345 f...
January 31, 2023, 9:30 am
Biomarin: opportunity to score home run with latest regulatory advancements
BioMarin Pharmaceutical Inc. revenues for Q3 of 2022 came in at $505.3 million, which was a year-over-year growth of 24%. It has potential to receive ...
January 30, 2023, 6:53 pm
Dupixent® (dupilumab) approved by european commission as the first and only targeted medicine indicated for eosinophilic esophagitis
Approximately 60% of patients aged 12 years and older treated with Dupixent 300 mg weekly in the pivotal trial experienced histological disease remiss...
January 30, 2023, 6:00 am
Cardiovascular disease linked to worse brain health in middle age: research
Cardiovascular diseases such as heart disease and stroke have been associated with an increased risk for cognitive impairment and dementia in older
January 28, 2023, 11:14 pm
Lilly (lly) jardiance kidney disease snda gets fda acceptance
Eli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney disease progression and cardiovascular death in <...
January 23, 2023, 12:03 pm
Mamamancini's holdings: the adults are now in charge
1300bp improvement Q/Q in gross margin shows new management focused on profitability, not just growing revenue. Already winning new customers and gett...
January 23, 2023, 10:30 am
Outside the box: ‘young people know more about tiktok and minecraft than money.’ teenagers want to be smarter about finances — teach them.
To raise financially secure adults, give high-school students lessons about responsible spending and saving. Read Full Story The post Outside the Box:...
January 20, 2023, 6:20 pm
Liqueurs market is expected to reach us$ 181.93 billion by 2033. the growing population of young-adults impacts the consumption of liqueurs says future market insights, inc.
With a growing population of young adults and higher levels of disposable income, the appetite for prem...
January 19, 2023, 5:30 pm
Nearly half of u.s. adults are unprepared to help in a medical emergency
WASHINGTON, D.C., Jan. 18, 2023 (GLOBE NEWSWIRE) — A new poll from the American College of Emergency Physicians (ACEP) and Morning Consult shows tha...
January 18, 2023, 5:02 pm
Moderna is the latest company to produce a promising rsv vaccine
Moderna's disclosure this week that its respiratory syncytial virus vaccine prevented most infections in older ...
January 18, 2023, 12:23 pm
Moderna (mrna) up on upbeat data from phase iii study on rsv jab
Data from a late-stage study showed that Moderna's (MRNA) RSV vaccine was 83.7% effective at preventing at least two symptoms in ...
January 18, 2023, 12:03 pm
Moderna shares soar on positive rsv vaccine trial results
Moderna Inc stock had added almost 6% on Wednesday morning after the biotechnology company reported positive results from a Phase 3 clinical study inv...
January 18, 2023, 11:41 am
What's happening to moderna shares on wednesday?
Shares of Moderna Inc (NASDAQ: MRNA) gained as much as 8.0% on Wednesday after the biotech giant reported promising results for its respiratory syncyt...
January 18, 2023, 11:32 am
Moderna comes swinging for pfizer, gsk as rsv vaccine battle heats up
Moderna stock jumped late Tuesday after the company said its experimental RSV vaccine proved nearly 84% effective in older adults. The post Moderna Co...
January 17, 2023, 5:03 pm
Moderna's phase three rsv trial found to be 83.7% effective in older adults
CNBC's Meg Tirrell joins 'Closing Bell' to discuss Moderna's phase three trial results for its RSV vaccine, the decision to submit the vaccine for reg...
January 17, 2023, 4:55 pm
Moderna says rsv vaccine is 84% effective at preventing disease in older adults
RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 ho...
January 17, 2023, 4:05 pm
Ipo update: quantasing readies $41 million u.s. ipo
QuantaSing Group Limited has filed proposed terms for a $41 million U.S. IPO. The firm provides online learning services for ...
January 16, 2023, 1:51 pm
Arcutis presents new phase 2 long-term data showing sustained efficacy and clearance for a median of 10 months with roflumilast cream in adults with chronic plaque psoriasis
During the open label trial, 57.1% of roflumilast-treated participants achieved Investigator Global Assessment (IGA) of clear or almost clear at any t...
January 14, 2023, 9:00 am
